Inactive Instrument

Medical & Biological Laboratories Co., Ltd. Stock

Equities

4557

JP3131450003

Dynamic Chart
Crown Bioscience and MBL Enter Joint Venture to Provide Advanced Preclinical Services for Japanese Customers CI
JSR Corporation acquired remaining 7.27% stake in Medical & Biological Laboratories Co., Ltd. for ¥1.7 billion. CI
JSR Corporation completed the acquisition of an additional 41.91% stake in Medical & Biological Laboratories Co., Ltd. for ¥9.5 billion. CI
JSR Corporation made an offer to acquire the remaining 49.2% stake in Medical & Biological Laboratories Co., Ltd. for ¥11.2 billion. CI
Medical & Biological Laboratories Co., Ltd. Starts the Sale of A Test Kit (For Research Use Only) for Measuring SARS-CoV-2 Neutralizing Antibodies CI
Medical & Biological Laboratories Co., Ltd. Announces “MEBRIGHTTM SARS-CoV-2 Kit” Was Approved with Marketing Authorization in Japan for the Detection of Novel Coronavirus “SARS-CoV-2” CI
Medical and Biological Laboratories Co., Ltd. Concludes License Agreement with China National Biotec Group Co., Ltd CI
Medical & Biological Laboratories Co., Ltd. Launches New ELISA-Based Companion Diagnostic Kit for Spinal Muscular Atrophy CI
Pmt Corporation Co. Ltd. cancelled the acquisition of Lifetech Co., Ltd from Medical & Biological Laboratories Co., Ltd. and others. CI
MEDICAL & BIOLOGICAL LABORATORIES Co., Ltd. Enters into Collaboration Agreement with the p53 Laboratory CI
Pmt Corporation Co. Ltd. agreed to acquire Lifetech Co., Ltd from Medical & Biological Laboratories Co., Ltd. and others for ¥0.07 million. CI
MBL International Corporation announced that it has received funding from JSR Micro, Inc., Medical & Biological Laboratories Co., Ltd. CI
MBL International Corporation announced that it expects to receive funding from JSR Micro, Inc., Medical & Biological Laboratories Co., Ltd. CI
Chiome Bioscience Inc. acquired remaining 47.1% stake in LivTech Inc. from Medical & Biological Laboratories Co., Ltd., KSP Inc., Kouji Nakamura, Hiroyuki Yanai and 3 other individuals. CI
JSR Corporation completed the acquisition of 13.88% stake in Medical & Biological Laboratories Co., Ltd. for ¥2.2 billion. CI
More news
Managers TitleAgeSince
Chief Executive Officer 68 09-03-31
Chief Tech/Sci/R&D Officer 65 83-03-31
Director/Board Member 56 16-03-31
Members of the board TitleAgeSince
Director/Board Member 66 13-05-31
Chief Executive Officer 68 09-03-31
Director/Board Member 67 10-04-30
More insiders
MEDICAL&BIOLOGICAL LABORATORIES CO., LTD. is a Japan-based company engaged in the research and development of clinical test drugs and basic research reagents, mainly for autoimmune diseases. The Company operates through two business segments. The Reagent segment is divided into the clinical diagnostics business and the life science translational research (LSTR) business. The main business is the research, development, manufacture and sales of clinical diagnostics and reagents related to basic research. This segment also sells related equipment and instruments, develops genetic test agents, prepares pathological specimens, and contracts for pathological diagnosis. The Investment segment is involved in the investment and cultivation of venture companies through venture capital funds.
Sector
-
More about the company